Petrus Trust Company’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,362
| Closed | -$242K | – | 779 |
|
|
2023
Q4 | $242K | Hold |
8,362
| – | – | 0.02% | 514 |
|
|
2023
Q3 | $231K | Hold |
8,362
| – | – | 0.02% | 487 |
|
|
2023
Q2 | $251K | Buy |
+8,362
| New | +$251K | 0.03% | 455 |
|
|
2020
Q3 | – | Sell |
-11,876
| Closed | -$282K | – | 361 |
|
|
2020
Q2 | $282K | Buy |
+11,876
| New | +$282K | 0.03% | 92 |
|
|
2019
Q3 | – | Sell |
-6,217
| Closed | -$206K | – | 346 |
|
|
2019
Q2 | $206K | Sell |
6,217
-3,729
| -37% | -$124K | 0.04% | 225 |
|
|
2019
Q1 | $349K | Buy |
9,946
+2,572
| +35% | +$90.3K | 0.07% | 82 |
|
|
2018
Q4 | $245K | Buy |
+7,374
| New | +$245K | 0.05% | 134 |
|
|
2018
Q3 | – | Sell |
-4,966
| Closed | -$297K | – | 328 |
|
|
2018
Q2 | $297K | Sell |
4,966
-5,376
| -52% | -$322K | 0.06% | 128 |
|
|
2018
Q1 | $474K | Buy |
10,342
+4,630
| +81% | +$212K | 0.11% | 59 |
|
|
2017
Q4 | $228K | Buy |
+5,712
| New | +$228K | 0.06% | 133 |
|
|
2017
Q3 | – | Sell |
-6,470
| Closed | -$279K | – | 214 |
|
|
2017
Q2 | $279K | Sell |
6,470
-7,160
| -53% | -$309K | 0.06% | 118 |
|
|
2017
Q1 | $427K | Buy |
13,630
+1,823
| +15% | +$57.1K | 0.1% | 71 |
|
|
2016
Q4 | $298K | Sell |
11,807
-3,949
| -25% | -$99.7K | 0.07% | 95 |
|
|
2016
Q3 | $390K | Buy |
15,756
+4,099
| +35% | +$101K | 0.09% | 66 |
|
|
2016
Q2 | $237K | Buy |
+11,657
| New | +$237K | 0.05% | 106 |
|